Skip to content

Ovitex® PRS R20143-1620PRecalls & reported problems

Aroa Biosurgery Limited · Ovitex® PRS is for implantation to reinforce soft tissue where weakness exists in patients requiring soft tissue repair or reinforcement in plastic and reconstructive surgery. The device is supplied sterile and is intended for one-time use. · Class 2 · Implant

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 09421905067706), received between Aug 7, 2024 and Aug 7, 2024 — classified as 1 injury.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 1 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem1

Patient problems

  • Bacterial Infection1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryAug 7, 2024Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    A PATIENT SELF REPORTED ONGOING LEFT BREAST INFECTION AFTER BILATERAL IMPLANT BASED BREAST RECONSTRUCTION WITH OVITEX PRS PERMANENT. IT WAS REPORTED THAT AN INFECTION DEVELOPED AFTER THE ORIGINAL SURGERY WHICH RESULTED IN THE REMOVAL OF THE IMPLANT AND OVITEX PRS DEVICE. THE PATIENT REPORTED ONGOING INFECTION IN THE LEFT BREAST AND "ISSUES IN THE LEFT IMPLANT" EVEN AFTER THE REMOVAL OF THESE ORIGINAL DEVICES. THE PATIENT ALSO EXPERIENCED REDNESS AND HEAT ON THE AFFECTED BREAST. THEY ALSO NOTED A LACK OF ENERGY, SPORADIC FEVERS, AND GENERAL MALAISE. NO RESOLUTION WAS NOTED IN THE REPORT.

    Patient problems: Bacterial Infection

    MAUDE report 19930628 ↗

Other Mesh, Surgical devices

All Mesh, Surgical devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page